Agentix Corp. (AGTX) stock
AGTXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
$0.02+0.00 (0.00%)
Close on Oct 16, 2026Market cap $801.34KP/E –Yield –
Agentix total assets
Total assets on the balance sheet at the end of each period.
Agentix's total assets was $38 at Jun 30, 2026. For fiscal 2026 it was $771, down 99.2% from the year before. Over ten years it grew -40.5% a year on average. The highest annual figure on record is $292.75K in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $771 | -99.2% |
| FY2025 | Mar 31, 2025 | $100.27K | -5.7% |
| FY2024 | Mar 31, 2024 | $106.37K | +107.7% |
| FY2021 | Aug 31, 2021 | $51.21K | -82.5% |
| FY2020 | Aug 31, 2020 | $292.75K | +314684.9% |
| FY2019 | Aug 31, 2019 | $93 | -95.9% |
| FY2018 | Aug 31, 2018 | $2.27K | -68.1% |
| FY2017 | Aug 31, 2017 | $7.09K | +451.0% |
| FY2016 | Aug 31, 2016 | $1.29K | -92.7% |
| FY2015 | Aug 31, 2015 | $17.52K | -87.4% |
| FY2014 | Aug 31, 2014 | $139.53K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $38 | -99.1% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $771 | -99.2% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $6.40K | -95.8% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $5.60K | -96.7% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $4.41K | -97.4% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $100.27K | -5.7% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $154.11K | +37.7% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $169.96K | -49.1% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $166.95K | -49.5% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $106.37K | +107.7% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $111.95K | +93.7% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $333.70K | +556.3% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $330.50K | +441.0% |
| Q4 FY2021CQ3 2021 | Aug 31, 2021 | $51.21K | -82.5% |
| Q3 FY2021CQ2 2021 | May 31, 2021 | $57.81K | +339947.1% |
| Q2 FY2021CQ1 2021 | Feb 28, 2021 | $50.84K | +391000.0% |
| Q1 FY2021CQ4 2020 | Nov 30, 2020 | $61.09K | +100044.3% |
| Q4 FY2020CQ3 2020 | Aug 31, 2020 | $292.75K | +314684.9% |
| Q3 FY2020CQ2 2020 | May 31, 2020 | $17 | -73.4% |
| Q2 FY2020CQ1 2020 | Feb 29, 2020 | $13 | -98.7% |
| Q1 FY2020CQ4 2019 | Nov 30, 2019 | $61 | -98.0% |
| Q4 FY2019CQ3 2019 | Aug 31, 2019 | $93 | -95.9% |
| Q3 FY2019CQ2 2019 | May 31, 2019 | $64 | -91.6% |
| Q2 FY2019CQ1 2019 | Feb 28, 2019 | $1.01K | -46.0% |
| Q1 FY2019CQ4 2018 | Nov 30, 2018 | $3.05K | -69.1% |
| Q4 FY2018CQ3 2018 | Aug 31, 2018 | $2.27K | -68.1% |
| Q3 FY2018CQ2 2018 | May 31, 2018 | $766 | -93.2% |
| Q2 FY2018CQ1 2018 | Feb 28, 2018 | $1.87K | -84.1% |
| Q1 FY2018CQ4 2017 | Nov 30, 2017 | $9.87K | -61.6% |
| Q4 FY2017CQ3 2017 | Aug 31, 2017 | $7.09K | +451.0% |
| Q3 FY2017CQ2 2017 | May 31, 2017 | $11.24K | +454.3% |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | $11.78K | +6.9% |
| Q1 FY2017CQ4 2016 | Nov 30, 2016 | $25.72K | +143.3% |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | $1.29K | -92.7% |
| Q3 FY2016CQ2 2016 | May 31, 2016 | $2.03K | -94.5% |
| Q2 FY2016CQ1 2016 | Feb 29, 2016 | $11.02K | -75.8% |
| Q1 FY2016CQ4 2015 | Nov 30, 2015 | $10.57K | – |
| Q4 FY2015CQ3 2015 | Aug 31, 2015 | $17.52K | – |
| Q3 FY2015CQ2 2015 | May 31, 2015 | $37.17K | – |
| Q2 FY2015CQ1 2015 | Feb 28, 2015 | $45.58K | – |
See a number that looks wrong?